A meta-analysis showed that probiotic therapies can improve NAFLD by reducing AST, ALT, total cholesterol, TNF-α, and IR in four randomized trials involving 134 NAFLD and NASH patients (Kanda et al., 2020). Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.